11.2 Capital

11.2 Capital is a prominent investment firm that is dedicated to supporting visionary founders and entrepreneurs who are tackling the world's most pressing challenges through the use of emerging technologies. With a strong focus on areas such as AI, cybersecurity, quantum computing, robotics, new space technologies, data-driven healthcare, and climate tech, 11.2 Capital aims to be at the forefront of innovation and drive positive change.

One of the core beliefs of 11.2 Capital is that exceptional people are key indicators of a company's success. They recognize that talented individuals with a deep understanding of their field and a passion for solving complex problems can truly make a difference. With this in mind, 11.2 Capital leverages its technical background, operational experience, and extensive network of advisors and partners to provide entrepreneurs with a unique set of resources.

The firm takes a hands-on approach to investing and strives to be one of the most helpful partners for early-stage companies. They offer support in various areas, including technical recruiting, forming strategic partnerships, making introductions to potential customers, and facilitating follow-on financings. By assisting with these crucial aspects of business development, 11.2 Capital aims to empower entrepreneurs and help them build extraordinary companies.

11.2 Capital understands the importance of assembling a talented team capable of executing a company's vision. They utilize their expertise and network to identify and attract top technical talent, ensuring that companies have the right people in place to drive their innovation forward.

Strategic partnerships play a vital role in the growth of emerging technology companies. 11.2 Capital actively seeks out opportunities for original equipment manufacturer (OEM) partnerships and distribution partnerships, particularly for smart hardware companies. By leveraging their network and industry knowledge, they help entrepreneurs forge alliances that can accelerate product development, enhance market reach, and drive revenue growth.

Data-driven healthcare companies can benefit from 11.2 Capital's expertise in forming data partnerships. Recognizing the transformative potential of data-driven solutions in the healthcare industry, the firm facilitates partnerships that allow these companies to access and analyze relevant data sets, ultimately leading to improved patient outcomes and healthcare delivery.

Additionally, 11.2 Capital recognizes the value of customer introductions in specific industries. Security companies, make Chief Information Security Officer (CISO) introductions, enabling entrepreneurs to establish connections with key decision-makers who can help validate and adopt their innovative cybersecurity solutions. Similarly, healthcare companies, facilitate introductions to providers who can evaluate and potentially integrate their technologies into healthcare systems.

Furthermore, 11.2 Capital actively supports companies in securing follow-on financing. They understand that capital is essential for scaling operations and driving continued growth. By leveraging their network of investors and industry connections, they help entrepreneurs navigate the funding landscape and secure the necessary resources to propel their companies forward.

In summary, 11.2 Capital is a forward-thinking investment firm that focuses on supporting entrepreneurs who are using emerging technologies to address significant global challenges. Through their technical expertise, operational experience, and extensive network, they provide valuable resources to help early-stage companies thrive. By concentrating on areas such as technical recruiting, partnerships, customer introductions, and follow-on financings, 11.2 Capital strives to be an exceptionally supportive investor, contributing to the creation of extraordinary companies and innovations that shape the future.

• Innovative Solutions: The firm seeks to invest in companies with innovative healthcare solutions that have the potential to significantly improve patient care and outcomes.
• Experienced Management Team: 112 Capital looks for companies with experienced management teams that have a track record of success in the healthcare industry.
• Strong Market Potential: The firm seeks to invest in companies with strong market potential and a clear path to commercialization.
• Scalability: The firm looks for companies with solutions that can be scaled and have the potential to generate significant returns on investment.
• Competitive Advantage: 112 Capital seeks to invest in companies with a competitive advantage, such as proprietary technology, intellectual property, or strategic partnerships.
• Social Impact: The firm is committed to investing in companies that have the potential to generate positive social impact by improving healthcare outcomes for patients and communities.

• Patient-Centred Approach: The firm is committed to supporting innovative healthcare solutions that improve patient care and outcomes.
• Collaboration: 112 Capital believes in working closely with its portfolio companies and partners to provide support, guidance, and resources that can help them achieve their goals.
• Innovation: The firm seeks to identify and invest in companies that are at the forefront of innovation in the healthcare industry, with the potential to transform the way care is delivered.
• Integrity: 112 Capital operates with the highest standards of integrity, transparency, and ethics in all of its business dealings.
• Impact: The firm is focused on generating positive social impact by investing in companies that have the potential to make a significant difference in healthcare and patient outcomes.

112 Capital is a venture capital firm that focuses on investing in early-stage companies in the healthcare industry and security. The firm's mission is to identify and support innovative healthcare solutions that have the potential to transform patient care and improve healthcare outcomes.

In pursuing its mission, 112 Capital aims to provide its portfolio companies with more than just capital. The firm also provides strategic guidance, industry expertise, and access to a network of healthcare professionals and investors to help its portfolio companies grow and succeed.

112 Capital is a venture capital firm that invests in early-stage companies in the healthcare industry. Here are some examples of the firm's portfolio companies:

• Catamaran Bio: Catamaran Bio is a biotechnology company focused on developing therapies for rare genetic diseases. The company's lead product candidate is a gene therapy for a rare metabolic disorder called GM1 gangliosidosis.
• Jasper Therapeutics: Jasper Therapeutics is a biotechnology company focused on developing stem cell-based therapies for blood diseases and cancers. The company's lead product candidate is a treatment for acute myeloid leukaemia.
• Terns Pharmaceuticals: Terns Pharmaceuticals is a biopharmaceutical company focused on developing therapies for liver diseases. The company's lead product candidate is a treatment for non-alcoholic steatohepatitis (NASH).
• Theator: Theator is a healthcare technology company that uses artificial intelligence to improve surgical outcomes. The company's platform analyzes surgical videos to provide real-time feedback to surgeons and improve their decision-making.
• Excelra: Excelra is a data analytics company that provides insights to pharmaceutical and biotech companies to accelerate drug discovery and development. The company's platform uses artificial intelligence and machine learning to analyze large datasets and identify potential drug candidates.